Tag: Boehringer Ingelheim Pharmaceuticals
Boehringer Ingelheim gets FDA Fast Track for Jardiance as kidney disease...
The drug, also known as empagliflozin, was developed by Boehringer Ingelheim and Eli Lilly and Co.
Boehringer Ingelheim premieres COPD documentary
The Ridgefield company filmed the stories of three patients with chronic obstructive pulmonary disease.
DEEP recognizes green businesses in Connecticut
The Department of Energy and Environmental Protection recognizes 16 businesses and individuals for their efforts to protect the environment.